acetylcysteine and fluticasone

acetylcysteine has been researched along with fluticasone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
de Backer, WA; Demkow, U; Górecka, D; van Overveld, FJ; Zielinski, J1
Akkermans, R; Chavannes, N; Dekhuijzen, R; Muris, J; Schermer, T; van Schayck, O; van Weel, C; Wouters, E1

Trials

2 trial(s) available for acetylcysteine and fluticasone

ArticleYear
New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2005, Volume: 56 Suppl 4

    Topics: Acetylcysteine; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Androstadienes; Anti-Inflammatory Agents; Antioxidants; Double-Blind Method; Eosinophil Cationic Protein; Expectorants; Female; Fluticasone; Forced Expiratory Volume; Glutathione Peroxidase; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Male; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Sputum; Treatment Outcome

2005
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
    Respiratory medicine, 2009, Volume: 103, Issue:4

    Topics: Acetylcysteine; Adult; Aged; Androstadienes; Bronchitis, Chronic; Bronchodilator Agents; Expectorants; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Middle Aged; Netherlands; Primary Health Care; Pulmonary Disease, Chronic Obstructive; Quality of Life; Smoking; Treatment Outcome

2009

Other Studies

1 other study(ies) available for acetylcysteine and fluticasone

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004